Presentation Information
[2P-386]Balancing efficacy and ototoxicity in 2-hydroxypropyl-β-cyclodextrin therapy for Niemann-Pick disease type C by degree and pattern of substitution
*Mayuko Tanaka1, Akira Ishii1, Yusei Yamada2, Yuki Kondo3, Toru Miwa4, Hiroki Takeda5, Yorihisa Orita5, Toru Takeo6, Naomi Nakagata6, Taishi Higashi3, Keiichi Motoyama3, Hidetoshi Arima7, Takahiro Seki8, Yuki Kurauchi3, Hiroshi Katsuki3, Ryuji Ikeda2, Katsumi Higaki9, Muneaki Matsuo10, Tetsumi Irie3, Yoichi Ishitsuka3 (1. Grad Sch Pharm, Univ of Kumamoto, Kumamoto, Japan, 2. Dept of Pharm, Univ of Miyazaki Hospital, Miyazaki, Japan, 3. Grad Sch Life Sci, Univ of Kumamoto, Kumamoto, Japan, 4. Dept of Otorhinolaryngology, Mizoguchi Hospital, Univ of Teikyo, Kawasaki, Japan, 5. Dept of Otorhinolaryngology, Faculty of Medicine, Univ of Kumamoto, Kumamoto, Japan, 6. Ctr for Life Resource Development, Univ of Kumamoto, Kumamoto, Japan, 7. Fac Pharm Sci, Univ of Daiichi Pharmacy, Fukuoka, Japan, 8. Fac Pharm Sci, Univ of Himeji Dokkyo, Himeji, Japan, 9. Ctr for Research Infrastructure, Univ of Tottori, Tottori, Japan, 10. Dept of Pediatrics, Univ of Saga Hospital, Saga, Japan)
Keywords:
Niemann-Pick disease type C,2-hydroxypropyl-β-cyclodextrin,Degree of substitution
Password required to view
Please enter the password that will be sent to those who have paid the meeting participation fee.
*For free participants, the password will be sent after confirmation and approval by the meeting secretariat.
*For on-the-day cash payments, the password is printed on your name badge.
*For free participants, the password will be sent after confirmation and approval by the meeting secretariat.
*For on-the-day cash payments, the password is printed on your name badge.
Comment
To browse or post comments, you must log in.Log in